Mazur, Włodzimierz <br/><br/>
A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.  [electronic resource] 

 -  Medical science monitor : international medical journal of experimental and clinical research  Apr 2002 
 - CR257-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1234-1010 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abdominal Pain--chemically induced<br/>Adult<br/>Aged<br/>Alanine Transaminase--blood<br/>Angina Pectoris--complications<br/>Antiviral Agents--adverse effects<br/>Biomarkers<br/>Bronchopneumonia--chemically induced<br/>Colitis, Ulcerative--chemically induced<br/>DNA, Viral--blood<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Lamivudine--adverse effects<br/>Male<br/>Middle Aged<br/>Poland<br/>Reverse Transcriptase Inhibitors--adverse effects<br/>Safety<br/>Urinary Tract Infections--chemically induced<br/>Viral Load<br/>Viremia--drug therapy<br/>Virus Replication--drug effects